Clear Cell Technologies

Home

Who we are

CCT

Clear Cell Technologies or CCT, was set up in 2006. The main purpose of the company is to provide a wide range of products for the selection and treatment of stem cells from human cord blood and bone marrow.

Not only does CCT develop new products, it also provides the specialised laboratories with top quality media that are now otherwise produced in-house.
Our media and density gradients are produced in an ISO9001, ISO13485 certified production facility using state-of-art production and quality control techniques.

Products

At this time CCT provides 2 products:

  • StemClear: Density gradient with a density of 1.080g/mL. The gradient is based on silane-coated silica (no PVP) with very low endoxtoxin levels. StemClear is CE marked as a Class 2a medical device.
  • PBS: Phosphate buffer used for washing and diluting samples before or after density gradient selection.

    • News

    Clear Cell Technologies bvba will be present at the EBMT meeting in Firenze from March 30th to April 2nd 2008. Please visit us at booth 613 close to the poster exhibition area.

    This video demonstrates the use of StemClear density gradient centrifugation with bone marrow.
    Click here to view the video showing the use of StemClear density gradient centrifugation with cord blood.
    The validated technique shown in the video allows for centrifugation of up to 600mL of bone marrow at the same time for optimum efficiency in separating the white from the red blood cells.